From: Endotype-driven treatment in chronic upper airway diseases
Endotypes | Allergic rhinitis | Idiopathic rhinitis | Infectious rhinitis | CRSwNP | CRSsNP |
---|---|---|---|---|---|
Type 2 inflammation | |||||
Serum | Eosinophils* Total IgE Specific IgE ECP* | Â | Â | Eosinophils* Total IgE* IgE/SE-IgE* ECP* | Â |
Nasal fluids | Total/specific IgE* IL-5* IL-4, IL-13* Eosinophils* | Â | Â | Total/specific IgE* IL-5* IL4, IL-13 ECP/MPO ratio* ECP* | Â |
Non- type 2 inflammation | |||||
Nasal lavage/fluids |  |  | IL-1P, IL-6, IL-8, MPO IFNγ TNFα |  | IL-1P, IL-6, IL-8, MPO* IFNγ* IL-17, IL-22, TNFα* |
Nasal biopsy | Â | Â | Neutrophils | Â | Neutrophils |
Neurogenic endotype | |||||
Nasal fluids | Â | SP | Â | Â | Â |
Nasal biopsy | Â | TRPV1 | Â | Â | Â |
Barrier dysfunction | |||||
Nasal biopsy | ↓TER |  | ↓TER | ↓TER |  |
↓TJ |  | ↓TJ | ↓TJ | ↓TJ |